| Balance Sheet of Zydus Lifesciences (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
102.40 |
102.40 |
102.40 |
102.40 |
102.40 |
|
| Total Share Capital |
102.40 |
102.40 |
102.40 |
102.40 |
102.40 |
|
| Reserves and Surplus |
10,273.30 |
10,283.90 |
8,642.10 |
6,857.60 |
5,596.80 |
|
| Total Reserves and Surplus |
10,273.30 |
10,283.90 |
8,642.10 |
6,857.60 |
5,596.80 |
|
| Total Shareholders Funds |
10,375.70 |
10,386.30 |
8,744.50 |
6,960.00 |
5,699.20 |
|
| Minority Interest |
1,334.70 |
1,292.90 |
191.00 |
156.10 |
135.80 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
3,214.60 |
3,949.70 |
2,555.10 |
2,468.40 |
896.40 |
|
| Deferred Tax Liabilities [Net] |
209.90 |
252.30 |
282.10 |
116.40 |
200.90 |
|
| Other Long Term Liabilities |
47.10 |
75.30 |
53.70 |
62.80 |
36.60 |
|
| Long Term Provisions |
235.20 |
184.10 |
155.90 |
151.20 |
120.70 |
|
| Total Non-Current Liabilities |
3,706.80 |
4,461.40 |
3,046.80 |
2,798.80 |
1,254.60 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
3,826.50 |
3,196.90 |
2,557.50 |
2,476.90 |
1,210.90 |
|
| Trade Payables |
2,044.30 |
1,922.60 |
1,888.40 |
1,547.90 |
1,308.10 |
|
| Other Current Liabilities |
2,155.40 |
2,087.30 |
1,536.90 |
1,223.70 |
890.70 |
|
| Short Term Provisions |
243.20 |
135.70 |
100.20 |
57.30 |
51.30 |
|
| Total Current Liabilities |
8,269.40 |
7,342.50 |
6,083.00 |
5,305.80 |
3,461.00 |
|
| Total Capital And Liabilities |
23,686.60 |
23,483.10 |
18,065.30 |
15,220.70 |
10,550.60 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
5,452.20 |
5,105.90 |
3,815.70 |
3,290.40 |
2,606.70 |
|
| Intangible Assets |
1,386.80 |
1,768.80 |
1,281.60 |
1,315.30 |
246.60 |
|
| Capital Work-In-Progress |
741.50 |
837.20 |
1,527.20 |
1,543.30 |
950.80 |
|
| Fixed Assets |
7,580.50 |
7,711.90 |
6,624.50 |
6,149.00 |
3,804.10 |
|
| Non-Current Investments |
552.20 |
443.60 |
470.90 |
385.70 |
217.10 |
|
| Deferred Tax Assets [Net] |
852.90 |
970.30 |
924.60 |
895.50 |
518.50 |
|
| Long Term Loans And Advances |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Other Non-Current Assets |
594.10 |
570.20 |
430.30 |
618.80 |
835.90 |
|
| Total Non-Current Assets |
14,971.20 |
14,985.00 |
9,835.60 |
9,198.40 |
6,270.20 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
212.80 |
229.90 |
274.80 |
49.10 |
199.10 |
|
| Inventories |
2,789.00 |
2,688.00 |
2,385.30 |
1,803.70 |
1,337.10 |
|
| Trade Receivables |
3,663.20 |
3,950.80 |
3,206.30 |
2,277.50 |
1,746.60 |
|
| Cash And Cash Equivalents |
964.90 |
548.90 |
1,314.90 |
1,543.50 |
638.70 |
|
| Short Term Loans And Advances |
0.00 |
10.00 |
0.00 |
0.00 |
0.00 |
|
| OtherCurrentAssets |
1,085.50 |
1,070.50 |
1,048.40 |
348.50 |
358.90 |
|
| Total Current Assets |
8,715.40 |
8,498.10 |
8,229.70 |
6,022.30 |
4,280.40 |
|
| Total Assets |
23,686.60 |
23,483.10 |
18,065.30 |
15,220.70 |
10,550.60 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
1,053.70 |
930.00 |
667.40 |
629.30 |
556.00 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
72.97 |
72.97 |
72.97 |
72.97 |
72.97 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
198.80 |
93.20 |
108.30 |
62.60 |
47.90 |
|
| Non-Current Investments Unquoted Book Value |
1.80 |
2.00 |
1.90 |
1.70 |
1.70 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Current Investments Unquoted Book Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.80 |
|
Source : Dion Global Solutions Limited
